An increasing number of women who use estrogen patches to help deal with perimenopause and menopause symptoms have been scrambling to access their transdermal drug amid a nationwide shortage of the ...

The estradiol patch, a popular menopause treatment, has been growing in popularity. But lately, it's been in short supply.

Women are finally demanding hormone therapy to treat menopause. Unfortunately, the system is not quite meeting the moment.

FPA Women’s Health is the largest independent family planning service network in the United States, and the Twirla (levonorgestrel and ethinyl estradiol) transdermal system is now the exclusive patch ...

(CNN) — Emily Padgett has spent months trying to get her hands on estrogen patches, bouncing between pharmacies, transferring prescriptions and switching brands three times. For a couple of anxious ...

CHARLESTON, S.C., June 30, 2025 /PRNewswire/ -- Afaxys, Inc., a Public Benefit Corporation and first-of-its kind socially conscious healthcare company focused on serving public health professionals ...

Supply chain issues and high demand have led to estrogen patch shortages. Learn how to find your prescription or switch to an effective alternative.

The proportion of patients achieving a prostate-specific antigen nadir less than or equal to 0.2 ng/ml was exactly the same for patients treated with transdermal estradiol patches and those treated ...

With the removal of FDA warning labels, hormone therapy to treat symptoms of menopause has grown in popularity. Now some patients are reporting delays in filling prescriptions for estrogen patches.

Based on phase 3 trial findings, investigators conclude that transdermal estradiol should be a standard of care ADT option for patients with nonmetastatic prostate cancer. Transdermal estradiol (tE2) ...